发明名称 Intraoral dosage forms of glucagon
摘要 The present invention provides a composition (e.g., a pharmaceutical composition) comprising at least one delivery agent compound and glucagon. Preferably, the composition includes a therapeutically effective amount of glucagon and the delivery agent compound. The composition of the present invention facilitates the delivery of glucagon and increases its bioavailability compared to administration without the delivery agent compound.
申请公布号 US8975227(B2) 申请公布日期 2015.03.10
申请号 US200611994032 申请日期 2006.07.17
申请人 Emisphere Technologies, Inc. 发明人 Wang Nai Fang;Liu Puchun;Dinh Steven;Goldberg Michael M.;Arbit Ehud
分类号 A61K38/26;C07K14/605 主分类号 A61K38/26
代理机构 Blank Rome LLP 代理人 Blank Rome LLP
主权项 1. A dosage unit form comprising (a) glucagon, and (b) a delivery agent of the formulaand salts thereof, wherein: Ar is 2-hydroxyphenyl or 2-hydroxynaphthyl; Ar is optionally substituted with one or more of —OH, halogen, C1-C4 alkyl, C2-C4 alkenyl, C1-C4 alkoxy or C1-C4 haloalkoxy; R7 is selected from C4-C20 alkyl, C4-C20 alkenyl, phenyl, naphthyl, (C1-C10 alkyl) phenyl, (C2-C10 alkenyl)phenyl, (C1-C10 alkyl) naphthyl, (C2-C10 alkenyl)naphthyl, phenyl(C1-C10 alkyl), phenyl(C2-C10 alkenyl), naphthyl(C1 -C10 alkyl), or naphthyl(C2-C10 alkenyl); R8 is selected from hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C1-C4 alkoxy, and C1-C4 haloalkoxy; R7 is optionally substituted with C1-C4 alkyl, C2-C4 alkenyl, C1-C4 alkoxy, C1-C4 haloalkoxy, —OH, —SH, and —CO2R9, or any combination thereof; R9 is hydrogen, C1-C4 alkyl, or C2-C4 alkenyl; and R7 is optionally interrupted by oxygen, nitrogen, sulfur or any combination thereof, wherein the dosage unit form is suitable for intraoral administration.
地址 Roseland NJ US